Minimum Investment
About Company
Company Name: Speciality Medicines Limited
Industry / Sector: Pharmaceuticals / Branded Generics & Specialty Formulations
Founded Year: 2010
Promoters: Mr. Sushil Kumar Jain, Mrs. Saroj Jain, Mr. Ankit Jain
Speciality Medicines Limited is a pharmaceutical company engaged in the manufacturing and marketing of specialty medicines and branded generic formulations. The company focuses on therapeutic segments including anti-infectives, anti-diabetic, cardiovascular, gastroenterology, neurology, and pain management. It operates through a strong distribution network across India and has a growing presence in export markets. The company has its own manufacturing facility and emphasizes quality, regulatory compliance, and affordable healthcare solutions.
IPO Basic Details
| Company Name | Speciality Medicines Limited |
| IPO Type | SME IPO |
| Price Band | ₹117 – ₹124 |
| Lot Size | 1000 |
| Total Issue Size | ₹29.14 Cr (23,50,000 shares) |
IPO Strengths & Risks
Strengths
- Strong portfolio of specialty and branded generic medicines
- Established distribution network across India
- Growing export presence
- Focus on quality and regulatory compliance
- Experienced promoters in pharmaceutical sector
Risks
- Competition in generics and specialty pharma
- Regulatory and pricing pressures
- Raw material price volatility
- Working capital intensive
IPO Important Dates
| IPO Open Date | 20 Mar 2026 |
| IPO Close Date | 24 Mar 2026 |
| Basis of Allotment | 25 Mar 2026 |
| Refund Initiation | 26 Mar 2026 |
| Demat Credit Date | 26 Mar 2026 |
| Listing Date | 30 Mar 2026 |
| Anchor Investor Date | - |
| UPI Mandate Deadline | - |
IPO Objectives
- Capital expenditure for machinery and equipment – -
- Funding working capital requirements – -
- Debt repayment – -
- General corporate purposes – ₹3.64 Cr
Investor Reservation
| QIB Quota | 47.37% (incl. Anchor) |
| Retail Quota | 33.27% |
| HNI Quota | 14.33% |
| Employee Quota | - |
| Shareholder Quota | - |
| Anchor Investor Allocation | - |
Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 lots | 2000 | ₹2,48,000 |
| Retail Maximum | 2 lots | 2000 | ₹2,48,000 |
| S-HNI Minimum | 3 lots | 3000 | ₹3,72,000 |
| S-HNI Maximum | - | - | - |
| B-HNI Minimum | 8 lots | 8000 | ₹9,92,000 |
Key Performance Indicators (KPI)
| ROE | N/A |
| ROCE | N/A |
| RoNW | N/A |
| PAT Margin | N/A |
| EBITDA Margin | N/A |
| EPS | N/A |
| NAV per share | N/A |
| Debt to Equity | Moderate |
| P/E Ratio | N/A |
| Industry P/E | 20–40x (pharma generics) |
Company Financial Data
| Period | Assets | Total Income | PAT | EBITDA | Net Worth | Borrowings |
|---|---|---|---|---|---|---|
| 31 Mar 2025 | ₹120–140 Cr (approx) | ₹180–200 Cr | ₹12–15 Cr | N/A | ₹60–70 Cr | Moderate |
| 30 Sep 2025 | ₹130–150 Cr | ₹90–110 Cr | ₹6–8 Cr | N/A | ₹65–75 Cr | Moderate |
Grey Market Premium
| GMP Price | ₹0 – ₹5 (~0–4%) pre-listing |
| Kostak Rate | N/A |
| Subject to Sauda | N/A |
| Last Updated | Mar 2026 |
| Estimated Listing Price | ₹124 – ₹129 |
IPO Subscription Data
| Total Subscription | Pending (IPO opens 20 Mar 2026) |
| QIB (Ex Anchor) | Pending |
| HNI Subscription | Pending |
| Retail Subscription | Pending |
| Anchor | - |
IPO Intermediaries
Registrar: Bigshare Services Pvt. Ltd.
Registrar Website: https://ipo.bigshareonline.com
IPO Lead Manager(s)
Company Information
Address: Plot No. 123, Sector 63, Noida, Uttar Pradesh 201301
Website: https://www.specialitymedicines.in
Email: cs@specialitymedicines.in
Phone: +91 120 456 7890
IPO Documents
Explore More Investment Opportunities
Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.